Denali Therapeutics Stock Forecast

Stock Price Forecast

The 9 analysts with 12-month price forecasts for Denali Therapeutics stock have an average target of 30, with a low estimate of 25 and a high estimate of 36. The average target predicts an increase of 47.28% from the current stock price of 20.37.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$25	$30	$30	$36
Change	+22.73%	+47.28%	+47.28%	+76.73%

Analyst Ratings

The average analyst rating for Denali Therapeutics stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	7	6	7	7	5	5
Buy	8	7	7	6	6	5
Hold	1	0	0	0	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	16	13	14	13	12	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Thomas Shrader BTIG	BTIG	Strong Buy Maintains $32 → $36	Strong Buy	Maintains	$32 → $36	+76.73%	Mar 2, 2026
Rudy Li Wolfe Research	Wolfe Research	Hold Initiates n/a	Hold	Initiates	n/a	n/a	Feb 24, 2026
Thomas Shrader BTIG	BTIG	Strong Buy Reiterates $32	Strong Buy	Reiterates	$32	+57.09%	Feb 6, 2026
Michael Yee UBS	UBS	Strong Buy Initiates $25	Strong Buy	Initiates	$25	+22.73%	Jan 7, 2026
Laura Chico Wedbush	Wedbush	Buy Maintains $31 → $30	Buy	Maintains	$31 → $30	+47.28%	Dec 11, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

39.39M

Revenue Next Year

154.07M

from 39.39M

291.12%

from 39.39M

EPS This Year

-2.85

from -2.97

EPS Next Year

-2.54

from -2.85

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	48.66M	108.46M	330.53M	-	-	39.39M	154.07M
Revenue Growth	-85.50%	122.90%	204.74%	-	-	-	291.12%
EPS	-2.39	-2.60	-1.06	-2.57	-2.97	-2.85	-2.54
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	21	18

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	144.7M	368.5M
Avg	39.4M	154.1M
Low	5.9M	34.3M

Revenue Growth

Revenue Growth	2026	2027
High	-	835.5%
Avg	-	291.1%
Low	-	-12.9%

EPS Forecast

EPS	2026	2027
High	-1.47	-1.89
Avg	-2.85	-2.54
Low	-3.30	-3.15

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.